• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Mendel.ai Raises $2M to Launch AI-Powered Medical Matching Service

by Fred Pennic 07/13/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Mendel.ai, a San Francisco-based startup has raised $2 million in seed funding co-led by DCM Ventures and Bootstrap Lab to launch a new artificial intelligence engine for doctors. The company has developed a new artificial intelligence engine that enables doctors and patients to more quickly find the best diagnostic and treatment methods available for their patients’ medical conditions. Founded by Dr. Karim Galil, Mendel.ai has developed a sophisticated algorithm that understands the unstructured, natural language content within medical documents and is able to make exhaustive inferences without using pre-made, hard-coded rules – an undertaking that is too impractical for human experts to sustain over extended periods of time. Powered by a patient’s comprehensive medical record, rather than limited keywords, the search returns a fully personalized match and evaluates the patient’s eligibility for each suggested treatment. Mendel.ai has built a team of physicians to train the artificial intelligence with real patient data and work with hospitals and cancer genomics companies to improve and introduce Mendel.ai. Initially focus on connecting oncology and cancer patient populations with available clinical trials, the company has already successfully integrated the platform with the UCLA-affiliated Comprehensive Blood & Cancer Center (CBCC) in Bakersfield, CA. The integration will allow the Center’s doctors to quickly and easily match their patients with available clinical trials in a matter of minutes -- a time and resource intensive process that currently takes days or weeks to complete. The process for uncovering the latest, available treatments can often mean a patient never receives the treatment needed to save their life. “As a physician, I have lost patients and family members to terminal cancer diagnosis, only to learn later about clinical trials that could have saved their life,” says Dr. Karim Galil, founder of Mendel.ai in a statement. “Finding the right clinical trials can determine life or death for many cancer patients, but physicians just can’t humanly stay abreast of the thousands of available clinical trials. After realizing the terrible inefficiencies in recruitment procedures for clinical trials, we set out to fix what can potentially save millions of cancer patients.” I work with a San Francisco-based startup called which today announced it launched a new artificial intelligence engine that helps doctors and patients more quickly find the best diagnostic and treatment methods available for specific medical conditions — starting with cancer.

Mendel.ai, a San Francisco-based startup has raised $2 million in seed funding co-led by DCM Ventures and Bootstrap Lab to launch a new artificial intelligence engine for doctors. The company has developed a new artificial intelligence engine that enables doctors and patients to more quickly find the best diagnostic and treatment methods available for their patients’ medical conditions.

Founded by Dr. Karim Galil, Mendel.ai has developed a sophisticated algorithm that understands the unstructured, natural language content within medical documents and is able to make exhaustive inferences without using pre-made, hard-coded rules – an undertaking that is too impractical for human experts to sustain over extended periods of time.

Powered by a patient’s comprehensive medical record, rather than limited keywords, the search returns a fully personalized match and evaluates the patient’s eligibility for each suggested treatment. Mendel.ai has built a team of physicians to train the artificial intelligence with real patient data and work with hospitals and cancer genomics companies to improve and introduce Mendel.ai.

Initially focus on connecting oncology and cancer patient populations with available clinical trials, the company has already successfully integrated the platform with the UCLA-affiliated Comprehensive Blood & Cancer Center (CBCC) in Bakersfield, CA. The integration will allow the Center’s doctors to quickly and easily match their patients with available clinical trials in a matter of minutes — a time and resource intensive process that currently takes days or weeks to complete. The process for uncovering the latest, available treatments can often mean a patient never receives the treatment needed to save their life.

“As a physician, I have lost patients and family members to terminal cancer diagnosis, only to learn later about clinical trials that could have saved their life,” says Dr. Karim Galil, founder of Mendel.ai in a statement. “Finding the right clinical trials can determine life or death for many cancer patients, but physicians just can’t humanly stay abreast of the thousands of available clinical trials. After realizing the terrible inefficiencies in recruitment procedures for clinical trials, we set out to fix what can potentially save millions of cancer patients.”

 

I work with a San Francisco-based startup called  which today announced it launched a new artificial intelligence engine that helps doctors and patients more quickly find the best diagnostic and treatment methods available for specific medical conditions — starting with cancer.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI Engine, algorithms, Artificial Intelligence, Artificial Intelligence (AI) Software Platform, Artificial Intelligence Companies, DCM Ventures, Deep Learning, Machine Learning, Mendel.ai, Natural Language Processing (NLP), NLP engine, Patient-Provider Matching

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |